Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofol
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Anesthesia
Conditions
Anesthesia
Trial Timeline
Nov 1, 2010 โ Mar 1, 2011
NCT ID
NCT01260142About Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofol
Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofol is a approved stage product being developed by Eisai for Anesthesia. The current trial status is completed. This product is registered under clinical trial identifier NCT01260142. Target conditions include Anesthesia.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01260142 | Approved | Completed |
Competing Products
20 competing products in Anesthesia